Abstract
Introduction
Several important issues for the established association between tobacco smoking and upper-aerodigestive tract (UADT) cancer risks include the associations with smoking by cancer subsite, by type of tobacco, and among never alcohol drinkers, and the associations with involuntary smoking among nonsmokers. Our aim was to examine these specific issues in a large scale case-control study in Europe.
Methods
Analysis was performed on 2,103 UADT squamous cell carcinoma cases and 2,221 controls in the Alcohol-Related Cancers and Genetic Susceptibility in Europe (ARCAGE) project, a multicenter case-control study in 10 European countries. Unconditional logistic regression was performed to obtain odds ratios (OR) and 95% confidence intervals (CI).
Results
Compared to never tobacco smoking, current smoking was associated with UADT cancer risks (OR=6.72, 95% CI 5.45–8.30 for overall; 5.83, 4.50–7.54 for oral cavity and oropharynx; 12.19, 8.29–17.92 for hypopharynx and larynx; 4.17, 2.45–7.10 for esophagus). Among never drinkers, dose-response relationships with tobacco smoking packyears were observed for hypopharyngeal and laryngeal cancers (ptrend = 0.01), but not for oral cavity and oropharyngeal cancers (ptrend = 0.282). Among never smokers, ever exposure to involuntary smoking was associated with an increased risk of UADT cancers (OR=1.60, 95% CI 1.04–2.46).
Conclusion
Our results corroborate that tobacco smoking may play a stronger role in the development of hypopharyngeal and laryngeal cancers than that of oral cavity and oropharyngeal cancers among never drinkers and that involuntary smoking is an important risk factor for UADT cancers. Public health interventions to reduce involuntary smoking exposure could help reduce UADT cancer incidence.
Keywords: Active tobacco smoking, involuntary smoking, upper-aerodigestive-tract cancer
Introduction
Tobacco smoking has been established as a risk factor for upper aerodigestive tract (UADT, including oral cavity, pharynx, larynx, and esophagus) cancers (1); (2). Dose-response relationships for intensity (daily consumption), duration of smoking, and pack-years have been reported in numerous epidemiologic studies (1). Vineis et al. reported that the effects of ever exposure to tobacco smoking vary by subsite of the UADT (Average relative risk 4.0–5.0 for oral cavity and pharynx, 1.5–5.0 for esophagus, and 10.0 for larynx) (3).
Since alcohol drinking is also a strong risk factor for UADT cancer development, it is important to investigate the role of tobacco smoking with proper consideration of alcohol drinking as a strong confounding factor and a possible effect modifier. The International Head and Neck Cancer Epidemiology (INHANCE) consortium reported the effect of tobacco smoking on head and neck cancer among never alcohol drinkers (4). The association with tobacco smoking was found to be stronger for larynx than for oral cavity and pharynx (Odds ratio [OR]=6.84 for larynx, OR=1.35 for oral cavity, and OR=2.02 for pharynx). A limitation of the study was that the analyses were based on pooled data with different questionnaires.
While the relationship between active smoking and UADT cancer risks has been studied extensively, there are few previous studies on involuntary smoking and UADT cancer risks. Involuntary smoking has not been fully investigated due to the strong confounding by active tobacco smoking and the small number of cases who are nonsmokers. Approximately 7.5 million workers in 15 European Union countries were estimated to be exposed to involuntary smoking at least 75% of their working time in the early 1990s, and 24.6 million workers in the US were estimated to be ever exposed to involuntary smoking at work in the year 2000 (5);(6);(7). Although the excess risk might be moderate, its high prevalence makes it a critical environmental carcinogen. Only two individual studies have investigated the association between involuntary smoking and head and neck cancer risk with limited power to control for confounding by active smoking (8);(9). A recent pooled analysis from six studies has provided evidence for a carcinogenic effect of involuntary smoking on head and neck organs, particularly on the pharynx and the larynx (10).
Since smoking is a modifiable behavior by public health intervention, it is essential to investigate the associations in more detail between active smoking and involuntary smoking exposure and the risk of UADT cancers. We aim to assess the associations with tobacco smoking by cancer subsite among the overall study population and among never alcohol drinkers, to evaluate the associations with different types of tobacco smoking, and to investigate UADT cancer risk with involuntary smoking among never smokers in a large European multicenter study.
Materials and Methods
Study Population
Alcohol-Related Cancers and Genetic Susceptibility in Europe (ARCAGE) is a multicenter case-control study with recruitment in 14 centers from 10 European countries (Czech Republic, Croatia, France, Germany, Greece, Ireland, Italy, Norway, Spain and United Kingdom). The study was approved by the ethical review board of IARC, as well as the respective local boards in the participating centers. All subjects provided written informed consent for their participation in the study.
Details on the study design have been provided previously (11). Briefly, incident cases were identified from participating hospitals and were histologically or cytologically confirmed. Eligible cases were classified under specific ICD-O codes (C00, C01, C02, C03, C04, C05, C06, C09, C10, C12, C13, C14.0, C14.8, C15.0, C15.3, C15.4, C15.5, C15.8, C15.9, and C32), (11) including cancer of the oral cavity, pharynx (excluding nasopharynx), larynx and esophagus. Recruitment was conducted from 2002 to 2005 for all centers, except for the French center, where recruitment was conducted during 1987 to 1992. Cases were identified by participating hospitals within 6 months of diagnosis. Six cases were excluded from the analysis due to missing information on age, sex or education. Among the 2,286 UADT cancer cases, 92.3% of the cases were squamous cell carcinoma (SCC). We focused our analysis on cases with SCC histology, since the etiology of UADT cancer of other histologies may differ. Of the 2,103 UADT SCC cases, 993 were oral cavity/oropharyngeal cancers, 854 were hypopharyngeal/laryngeal cancer cases, 152 were esophageal cancer cases and 104 were overlapping oral cavity/pharyngeal cancer cases.
In each center, controls were frequency-matched to cases by sex, age, and referral (or residence) area. In the UK centers, population controls were randomly chosen from the same family medical practice list as the corresponding cases. In the remaining centers, however, hospital controls were used, in order to facilitate collection of blood samples. Only controls with a recently diagnosed disease were accepted, and admission diagnoses related to alcohol, tobacco or dietary practices were excluded. Eligible control admission diagnosis included 1) endocrine and metabolic 2) genitor-urinary 3) skin, subcutaneous tissue, and musculoskeletal, 4) gastro-intestinal, 5) circulatory, 6) ear, eye and mastoid, and 7) nervous system diseases, as well as 8) plastic surgery cases, and 9) trauma patients. The proportion of controls within a specific diagnostic group did not exceed 33% of the total. In the UK centers, population controls were recruited from a randomly selected list of ten controls for every case, matched by age, sex, and same family medical practice. After excluding six controls due to missing information on age, sex or education, 2,221 controls were included in the analysis. In the Paris center, by center-specific protocol, never smokers were not included among cases or controls (11).
Cases and controls underwent identical interviews during which they completed a lifestyle questionnaire. The questionnaire included information on socio-demographic variables, as well as detailed smoking and alcohol drinking histories. Nonsmokers were asked about the duration of exposure to involuntary smoking at home and at work, respectively. The participation rates ranged from 35% to 100% for cases and from 26% to 100% for controls. The UK centers with population-based recruitment had the lower participation rates, compared to the other centers.
Statistical Analysis
For the assessment of main effects of tobacco smoking (cigarette, cigar and pipe), all UADT cancer cases were analyzed both together and stratified by cancer subsite. The distribution of cases and controls by age, center, sex, education, and histology was examined. Odds ratios (OR) and 95% confidence intervals (95% CI) for UADT cancers by various tobacco smoking variables, including intensity (drinks/day), duration, pack-years, age at start, years since quitting, were estimated with unconditional logistic regression, adjusting for age (categories shown in Table 1), sex, education level (categories shown), and alcohol consumption (intensity and duration).
Table 1.
Demographic characteristics among UADT SCC cases and controls
| Overall | Never alcohol drinkers | |||||||
|---|---|---|---|---|---|---|---|---|
| Ca n | (%) | Co n | (%) | Ca n | (%) | Co n | (%) | |
| Total | 2103 | 2221 | 118 | 272 | ||||
| Center | ||||||||
| Czech Republic: Prague | 163 | (7.75) | 187 | (8.42) | 4 | (3.39) | 6 | (2.21) |
| Germany: Bremen | 277 | (13.17) | 327 | (14.72) | 9 | (7.63) | 26 | (9.56) |
| Greece: Athens | 211 | (10.03) | 194 | (8.73) | 20 | (16.95) | 35 | (12.87) |
| Italy: Aviano | 145 | (6.89) | 151 | (6.80) | 1 | (0.85) | 11 | (4.04) |
| Italy: Padova | 128 | (6.09) | 130 | (5.85) | 9 | (7.63) | 25 | (9.19) |
| Italy: Turin | 158 | (7.51) | 198 | (8.91) | 17 | (14.41) | 31 | (11.40) |
| Ireland: Dublin | 33 | (1.57) | 19 | (0.86) | 2 | (1.69) | 3 | (1.10) |
| Norway: Oslo | 137 | (6.51) | 184 | (8.28) | 8 | (6.78) | 16 | (5.88) |
| UK: Glasgow | 90 | (4.28) | 91 | (4.10) | 3 | (2.54) | 1 | (0.37) |
| UK: Manchester | 141 | (6.70) | 186 | (8.37) | 3 | (2.54) | 5 | (1.84) |
| UK: Newcastle | 67 | (3.19) | 113 | (5.09) | 2 | (1.69) | 4 | (1.47) |
| Spain: Barcelona | 184 | (8.75) | 166 | (7.47) | 24 | (20.34) | 84 | (30.88) |
| Croatia: Zagreb | 50 | (2.38) | 46 | (2.07) | 3 | (2.54) | 6 | (2.21) |
| France: Paris | 319 | (15.17) | 229 | (10.31) | 13 | (11.02) | 19 | (6.99) |
| Age | ||||||||
| <40 years | 48 | (2.28) | 107 | (4.82) | 8 | (6.78) | 21 | (7.72) |
| 40–44 years | 95 | (4.52) | 118 | (5.31) | 6 | (5.08) | 15 | (5.51) |
| 45–49 years | 212 | (10.08) | 193 | (8.69) | 5 | (4.24) | 22 | (8.09) |
| 50–54 years | 318 | (15.12) | 316 | (14.23) | 10 | (8.47) | 37 | (13.60) |
| 55–59 years | 444 | (21.11) | 386 | (17.38) | 22 | (18.64) | 36 | (13.24) |
| 60–64 years | 352 | (16.74) | 310 | (13.96) | 15 | (12.71) | 27 | (9.93) |
| 65–69 years | 306 | (14.55) | 341 | (15.35) | 18 | (15.25) | 35 | (12.87) |
| 70–74 years | 192 | (9.13) | 252 | (11.35) | 17 | (14.41) | 33 | (12.13) |
| 75+ years | 136 | (6.47) | 198 | (8.91) | 17 | (14.41) | 46 | (16.91) |
| p-value | <0.001 | 0.548 | ||||||
| Sex | ||||||||
| Men | 1712 | (81.41) | 1659 | (74.70) | 40 | (33.90) | 113 | (41.54) |
| Women | 391 | (18.59) | 562 | (25.30) | 78 | (66.10) | 159 | (58.46) |
| p-value | <0.001 | 0.155 | ||||||
| Education | ||||||||
| Finished primary school | 778 | (36.99) | 590 | (26.56) | 55 | (46.61) | 109 | (40.07) |
| Finished further school | 1197 | (56.92) | 1389 | (62.54) | 52 | (44.07) | 139 | (51.10) |
| University degree | 128 | (6.09) | 242 | (10.90) | 11 | (9.32) | 24 | (8.82) |
| p-value | <0.001 | 0.429 | ||||||
| Histology | ||||||||
| Controls | 2221 | (100.00) | 272 | (100.00) | ||||
| Oral/Oropharynx | 993 | (47.22) | 58 | (49.15) | ||||
| Hypopharynx/Larynx | 854 | (40.61) | 45 | (38.14) | ||||
| Esophagus | 152 | (7.23) | 13 | (11.02) | ||||
| Overlapping | 104 | (4.95) | 2 | (1.69) | ||||
Ever smokers were defined as individuals who ever smoked cigarettes, cigars, pipes or any tobacco products at least once a week for a year. Former smokers were defined as smokers who had stopped for at least 12 months. The Paris center included only regular smokers who smoked 5 cigarettes or cigars or pipes per day for 5 years. The different types of tobacco smoking were converted to cigarette equivalents (1 cigar = 4 cigarettes and 1 pipe = 3.5 cigarettes (1)). The main effect of tobacco smoking was also evaluated among never alcohol drinkers in order to see whether the effect of tobacco smoking is independent of alcohol drinking. In addition, interactions between tobacco smoking and alcohol drinking were assessed using stratified analysis and log-likelihood ratio tests. The involuntary smoking variables included ever exposure status and duration of exposure at home or at work, and were evaluated among never tobacco smokers only.
Statistics from multinomial logistic regression were obtained to assess heterogeneity across cancer subsites. The potential issue of multiple hypotheses testing was evaluated, using the approach described by Wacholder et al (12). A false positive report probability was calculated to test under a noteworthiness value of 0.2. Since the causal relationship between tobacco smoking and UADT cancer was biologically plausible (1), the prior probability of the hypotheses was set to be 0.25. Statistical analyses were conducted using the SAS 9 statistical software. All p-values were two-sided.
Results
The demographic characteristics of the cases and controls in the 14 study centers are reported in Table 1. The proportions of women and participants with higher education were greater among controls than cases (25.30% female controls vs. 18.59% female cases; 10.90% highly educated controls vs. 6.09% highly educated cases) in the overall population. The distributions were similar between cases and controls among never alcohol drinkers.
For tobacco smoking, dose-response trends were consistently observed with the risk of UADT SCC for intensity, duration, packyears (Table 2) and lifetime exposure (data not shown) for all of the UADT cancer subsites. The risk of hypopharyngeal and laryngeal SCC associated with tobacco smoking was higher than that of oral cavity/oropharyngeal and esophageal SCCs, regardless of the tobacco measurement considered. After adjustment for packyears of smoking and without adjustment for age, starting tobacco smoking at a young age (<15 years) did not confer a higher risk of UADT SCCs than starting at a later age (≥20 years). We performed heterogeneity tests by sex (results not shown). However, the data for women became too sparse to provide meaningful comparisons except for tobacco among the overall participants. The point estimates suggested stronger associations with tobacco smoking among men than those among women although the 95% confidence intervals overlapped.
Table 2.
Associations between tobacco smoking and UADT cancer risk by cancer subsite
| UADT | Oral cavity & oropharynx | Hypopharynx & larynx | Esophagus | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | |
| Tobacco smoking status1 | ||||||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | 25 | 632 | 1.00 | ||||
| Former | 479 | 741 | 2.26 | (1.82– 2.81) | 205 | 741 | 1.80 | (1.37– 2.37) | 223 | 741 | 4.41 | (2.98– 6.53) | 37 | 587 | 1.77 | (1.00– 3.12) |
| Current | 1390 | 715 | 6.72 | (5.45– 8.30) | 660 | 715 | 5.83 | (4.50– 7.54) | 568 | 715 | 12.19 | (8.29– 17.92) | 85 | 509 | 4.17 | (2.45– 7.10) |
| Tobacco smoking intensity1 | ||||||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | 25 | 632 | 1.00 | ||||
| >0–2 cigarettes/day | 27 | 44 | 2.67 | (1.58– 4.52) | 14 | 44 | 2.44 | (1.27– 4.69) | 9 | 44 | 4.04 | (1.77– 9.24) | 1 | 33 | 0.97 | (0.12– 7.97) |
| 3–4 cigarettes/day | 31 | 49 | 2.78 | (1.69– 4.55) | 18 | 49 | 2.76 | (1.51– 5.02) | 8 | 49 | 3.23 | (1.39– 7.49) | 2 | 43 | 2.21 | (0.48– 10.19) |
| 5–10 cigarettes/day | 172 | 301 | 2.21 | (1.70– 2.87) | 92 | 301 | 1.99 | (1.44– 2.75) | 55 | 301 | 3.50 | (2.20– 5.56) | 21 | 254 | 2.16 | (1.13– 4.13) |
| 11–20 cigarettes/day | 808 | 598 | 4.95 | (3.99– 6.13) | 384 | 598 | 4.24 | (3.26– 5.52) | 315 | 598 | 8.38 | (5.68– 12.35) | 67 | 471 | 3.59 | (2.10– 6.14) |
| >20 cigarettes/day | 822 | 461 | 5.91 | (4.69– 7.45) | 352 | 461 | 4.85 | (3.64– 6.47) | 400 | 461 | 11.28 | (7.59– 16.77) | 31 | 293 | 2.58 | (1.37– 4.88) |
| Ptrend | <0.001 | <0.001 | <0.001 | 0.313 | ||||||||||||
| Tobacco smoking duration1 | ||||||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | 25 | 632 | 1.00 | ||||
| 1–20 years | 153 | 404 | 1.49 | (1.15– 1.94) | 80 | 404 | 1.31 | (0.94– 1.83) | 49 | 404 | 2.13 | (1.33– 3.41) | 17 | 308 | 1.88 | (0.95– 3.74) |
| 21–40 years | 1040 | 737 | 4.50 | (3.64– 5.56) | 488 | 737 | 3.76 | (2.90– 4.87) | 436 | 737 | 8.01 | (5.46– 11.75) | 65 | 545 | 2.70 | (1.57– 4.64) |
| >40 years | 669 | 313 | 7.67 | (6.03– 9.75) | 293 | 313 | 6.81 | (5.06– 9.16) | 303 | 313 | 13.38 | (8.92– 20.09) | 40 | 241 | 4.05 | (2.21– 7.42) |
| Ptrend | <0.001 | <0.001 | <0.001 | 0.024 | ||||||||||||
| Tobacco age at start2 | ||||||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | 25 | 632 | 1.00 | ||||
| 20+ years | 523 | 423 | 3.09 | (2.44– 3.92) | 239 | 423 | 3.08 | (2.31– 4.11) | 221 | 423 | 5.38 | (3.57– 8.12) | 44 | 305 | 2.68 | (1.49– 4.84) |
| 15–19 years | 911 | 756 | 2.68 | (2.14– 3.37) | 421 | 756 | 2.65 | (2.02– 3.48) | 386 | 756 | 4.84 | (3.25– 7.20) | 56 | 582 | 1.70 | (0.94– 3.10) |
| <15 years | 425 | 274 | 2.59 | (1.96– 3.41) | 199 | 274 | 2.74 | (1.98– 3.80) | 180 | 274 | 4.35 | (2.79– 6.78) | 22 | 207 | 1.64 | (0.75– 3.60) |
| Ptrend | 0.094 | 0.333 | 0.147 | 0.086 | ||||||||||||
| Smoking status & packyears3 | ||||||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | 25 | 632 | 1.00 | ||||
| former (>0–20 py) since ≥20 yr | 80 | 263 | 1.26 | (0.92– 1.72) | 40 | 263 | 1.09 | (0.73– 1.64) | 25 | 263 | 1.71 | (0.99– 2.97) | 13 | 213 | 1.98 | (0.95– 4.11) |
| former (>20 py) since ≥20 yr | 42 | 95 | 1.59 | (1.03– 2.43) | 19 | 95 | 1.49 | (0.84– 2.63) | 23 | 95 | 3.12 | (1.70– 5.71) | 75 | |||
| former (>0–20 py) since <20 yr | 75 | 132 | 2.41 | (1.72– 3.37) | 40 | 132 | 2.13 | (1.40– 3.25) | 29 | 132 | 4.66 | (2.70– 8.04) | 5 | 110 | 1.15 | (0.40– 3.29) |
| former (>20 py) since <20 yr | 284 | 247 | 4.24 | (3.27– 5.49) | 106 | 247 | 3.05 | (2.19– 4.25) | 148 | 247 | 8.69 | (5.70– 13.23) | 19 | 184 | 2.63 | (1.33– 5.21) |
| current (>0–20 py) | 173 | 219 | 3.53 | (2.68– 4.66) | 102 | 219 | 3.42 | (2.45– 4.78) | 46 | 219 | 4.75 | (2.90– 7.77) | 13 | 174 | 2.60 | (1.21– 5.58) |
| current (21–40 py) | 527 | 258 | 7.89 | (6.18– 10.07) | 257 | 258 | 6.65 | (4.95– 8.93) | 197 | 258 | 13.80 | (9.12– 20.89) | 48 | 188 | 6.13 | (3.38– 11.11) |
| current (>40 py) | 688 | 244 | 9.93 | (7.73– 12.77) | 298 | 244 | 8.46 | (6.22– 11.50) | 325 | 244 | 18.32 | (12.14– 27.63) | 24 | 147 | 3.21 | (1.62– 6.38) |
| Ptrend | <0.001 | <0.001 | <0.001 | <0.001 | ||||||||||||
Adjusted for age, sex, education, center, and alcohol drinking frequency (continuous) and duration (continuous)
Adjusted for sex, education, center, and alcohol drinking frequency (continuous) and duration (continuous), packyears of smoking (continuous)
Adjusted for age, sex, education, center and alcohol drinking frequency (continuous)
Ptrends were calculated among ever smokers only
Tobacco smoking includes cigarettes, cigar, and pipe in cigarette equivalents.
In Table 3, UADT SCC risk due to the different types of tobacco smoking products were assessed. The risk of oral cavity/oropharyngeal SCC was increased by approximately 5-fold for smoking >20 cigarettes per day, 8-fold for smoking >20 cigarette equivalents of cigars and 4-fold for smoking >20 cigarette equivalents of pipes. For oral cavity/oropharyngeal SCC, the risk estimates with smoking intensity and duration were suggested to be higher for cigar smoking than for cigarette or pipe smoking. On the other hand, for hypopharyngeal and laryngeal SCC, the point estimates with smoking intensity and duration were suggested to be higher for cigar smoking only at low intensity (≤10 cigarettes/day) and short duration (<20 years). Similar evaluations were performed for esophageal cancer, but the data were too sparse to provide reliable estimates (results not shown).
Table 3.
Associations between tobacco smoking and UADT cancer risk by subsite for different types of tobacco products
| UADT | Oral cavity & oropharynx | Hypopharynx & larynx | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | |
| Cigarette smoking frequency1 | ||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >0–10 cigarettes/day | 238 | 402 | 2.35 | (1.84– 2.99) | 131 | 402 | 2.20 | (1.63– 2.96) | 74 | 402 | 3.50 | (2.26– 5.43) |
| 11–20 cigarettes/day | 827 | 612 | 4.95 | (4.00– 6.13) | 390 | 612 | 4.19 | (3.22– 5.46) | 327 | 612 | 8.40 | (5.70– 12.37) |
| >20 cigarettes/day | 779 | 408 | 6.23 | (4.93– 7.88) | 332 | 408 | 5.05 | (3.78– 6.76) | 378 | 408 | 11.91 | (8.00– 17.74) |
| Ptrend | <0.001 | <0.001 | <0.001 | |||||||||
| Cigarette smoking duration1 | ||||||||||||
| never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >1–9 years | 54 | 141 | 1.60 | (1.11– 2.30) | 30 | 141 | 1.52 | (0.96– 2.40) | 14 | 141 | 1.87 | (0.96– 3.64) |
| 10–19 years | 114 | 225 | 2.01 | (1.50– 2.70) | 58 | 225 | 1.75 | (1.20– 2.54) | 42 | 225 | 3.30 | (2.01– 5.41) |
| 20–39 years | 975 | 724 | 4.28 | (3.46– 5.29) | 459 | 724 | 3.58 | (2.76– 4.65) | 406 | 724 | 7.68 | (5.23– 11.28) |
| 40+ years | 703 | 333 | 7.20 | (5.68– 9.12) | 307 | 333 | 6.30 | (4.71– 8.42) | 318 | 333 | 12.93 | (8.64– 19.34) |
| Ptrend | <0.001 | <0.001 | <0.001 | |||||||||
| Cigar smoking frequency2 | ||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >0–10 cigarette equivalents/day | 61 | 41 | 6.24 | (2.80– 13.89) | 23 | 41 | 5.14 | (1.81– 14.56) | 33 | 41 | 8.36 | (2.87– 24.37) |
| 11–20 cigarette equivalents/day | 32 | 26 | 5.03 | (2.06– 12.30) | 16 | 26 | 6.26 | (2.01– 19.47) | 15 | 26 | 4.53 | (1.33– 15.45) |
| >20 cigarette equivalents/day | 37 | 38 | 6.02 | (2.52– 14.37) | 21 | 38 | 7.66 | (2.71– 21.62) | 14 | 38 | 3.93 | (1.12– 13.73) |
| Ptrend | 0.863 | 0.358 | 0.083 | |||||||||
| Cigar smoking duration2 | ||||||||||||
| never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >1–9 years | 63 | 56 | 4.98 | (2.23– 11.12) | 32 | 56 | 6.23 | (2.30– 16.85) | 27 | 56 | 5.64 | (1.89– 16.79) |
| 10–19 years | 23 | 21 | 5.31 | (2.07– 13.64) | 8 | 21 | 4.14 | (1.22– 14.09) | 14 | 21 | 7.52 | (2.17– 26.01) |
| 20–39 years | 35 | 25 | 8.22 | (3.42– 19.74) | 18 | 25 | 10.61 | (3.40– 33.06) | 15 | 25 | 6.79 | (2.02– 22.86) |
| 40+ years | 11 | 6 | 11.18 | (2.67– 46.80) | 3 | 6 | 11.90 | (1.55– 91.67) | 7 | 6 | 10.36 | (1.80– 59.54) |
| Ptrend | 0.093 | 0.247 | 0.450 | |||||||||
| Pipe smoking frequency2 | ||||||||||||
| Never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >0–10 cigarette equivalents/day | 50 | 52 | 5.47 | (2.53– 11.84) | 30 | 52 | 6.54 | (2.54– 16.82) | 15 | 52 | 4.14 | (1.29– 13.33) |
| 11–20 cigarette equivalents/day | 22 | 39 | 3.02 | (1.24– 7.36) | 9 | 39 | 2.65 | (0.80– 8.75) | 10 | 39 | 3.44 | (1.01– 11.66) |
| >20 cigarette equivalents/day | 40 | 54 | 5.02 | (2.11– 11.95) | 16 | 54 | 4.15 | (1.34– 12.88) | 17 | 54 | 6.19 | (1.76– 21.81) |
| Ptrend | 0.721 | 0.231 | 0.449 | |||||||||
| Pipe smoking duration2 | ||||||||||||
| never | 179 | 712 | 1.00 | 109 | 712 | 1.00 | 34 | 712 | 1.00 | |||
| >1–9 years | 65 | 101 | 3.21 | (1.47– 7.02) | 31 | 101 | 3.56 | (1.34– 9.49) | 27 | 101 | 3.81 | (1.25– 11.57) |
| 10–19 years | 16 | 20 | 5.37 | (2.00– 14.41) | 6 | 20 | 4.19 | (1.15– 15.21) | 5 | 20 | 4.19 | (0.94– 18.79) |
| 20–39 years | 29 | 20 | 9.57 | (4.00– 22.88) | 18 | 20 | 15.90 | (5.43– 46.56) | 8 | 20 | 6.11 | (1.63– 22.95) |
| 40+ years | 5 | 6 | 5.68 | (1.32– 24.40) | 1 | 6 | 3.61 | (0.32– 40.45) | 4 | 6 | 10.35 | (1.86– 57.72) |
| Ptrend | 0.005 | 0.004 | 0.157 | |||||||||
Adjusted for age, sex, education, center, alcohol drinking frequency and duration
Adjusted for age, sex, education, center, alcohol drinking intensity and duration, and smoking duration
Ptrends were calculated among ever smokers only
1 cigar = 4 cigarette and 1 pipe = 3.5 cigarettes for comparison purpose.
Esophageal cancer patients were not included due to sparse data.
Among never alcohol drinkers, dose-response trends were observed for packyears of smoking for hypopharyngeal and laryngeal SCC (p-value for trend 0.010; Table 4). On the other hand, the dose-response trends were not detected for oral cavity and oropharyngeal SCC. Under multiplicative models, interactions between measures of tobacco consumption (smoking status, intensity, duration and packyears) and alcohol drinking intensity were detected for oral cavity and oropharyngeal cancers (data not shown; p-value = 0.004 for smoking status, 0.031 for smoking intensity, <0.001 for smoking duration and accumulative lifetime exposure, and 0.024 for packyears of smoking). Such interactions were not observed for the other UADT cancer subsites. The data became too sparse to examine the relationship with any specific tobacco type other than cigarettes or for esophageal SCC.
Table 4.
Associations between tobacco smoking and UADT cancer risk by cancer subsite among never alcohol drinkers
| UADT | Oral cavity & oropharynx | Hypopharynx & larynx | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | Ca | Co | OR | 95% CI | |
| Tobacco smoking status | ||||||||||||
| Never | 45 | 166 | 1.00 | 33 | 166 | 1.00 | 5 | 166 | 1.00 | |||
| Former | 18 | 52 | 1.55 | (0.77– 3.10) | 5 | 52 | 0.62 | (0.21– 1.82) | 12 | 52 | 10.32 | (2.77– 38.47) |
| Current | 55 | 54 | 5.15 | (2.80– 9.45) | 20 | 54 | 2.26 | (1.02– 5.03) | 28 | 54 | 47.32 | (12.05– 185.80) |
| P | 0.001 | 0.032 | 0.002 | |||||||||
| Tobacco smoking intensity | ||||||||||||
| Never | 45 | 166 | 1.00 | 33 | 166 | 1.00 | 5 | 166 | 1.00 | |||
| >0–10 cigaretts/day | 18 | 28 | 2.62 | (1.26– 5.45) | 8 | 28 | 1.49 | 0.57– 3.89) | 8 | 28 | 16.33 | (4.14– 64.36) |
| 11–20 cigarettes/day | 29 | 41 | 3.49 | (1.79– 6.80) | 10 | 41 | 1.25 | 0.49– 3.16) | 14 | 41 | 21.27 | (5.63– 80.40) |
| >20 cigarettes/day | 25 | 36 | 3.44 | (1.64– 7.22) | 7 | 36 | 1.60 | 0.54– 4.73) | 17 | 36 | 21.99 | (5.62– 86.02) |
| Ptrend | 0.574 | 0.925 | 0.651 | |||||||||
| Tobacco smoking duration | ||||||||||||
| Never | 45 | 166 | 1.00 | 33 | 166 | 1.00 | 5 | 166 | 1.00 | |||
| 1–20 years | 15 | 30 | 1.99 | (0.88– 4.48) | 6 | 30 | 0.92 | (0.28– 3.00) | 7 | 30 | 11.14 | (2.54– 48.77) |
| 21–40 years | 31 | 55 | 2.76 | (1.44– 5.30) | 8 | 55 | 0.92 | (0.35– 2.40) | 19 | 55 | 18.57 | (5.07– 68.04) |
| >40 years | 26 | 20 | 5.48 | (2.50– 12.01) | 11 | 20 | 3.30 | (1.17– 9.32) | 13 | 20 | 30.45 | (7.50– 123.70) |
| Ptrend | 0.050 | 0.089 | 0.157 | |||||||||
| Tobacco smoking lifetime | ||||||||||||
| Never | 45 | 166 | 1.00 | 33 | 166 | 1.00 | 5 | 166 | 1.00 | |||
| >0–50,000 cigarettes/life | 8 | 19 | 1.70 | (0.64 | 2 | 19 | 0.44 | (0.09– 2.20) | 4 | 19 | 15.43 | (2.91– 81.82) |
| >50,000–100,000 cigarettes/life | 10 | 9 | 5.19 | (1.80 | 6 | 9 | 4.45 | (1.19– 16.56) | 4 | 9 | 23.81 | (3.96– 143.00) |
| >100,000–500,000cigarettes/life | 45 | 72 | 3.08 | (1.72– 5.54) | 16 | 72 | 1.41 | (0.63– 3.12) | 23 | 72 | 17.79 | (5.08– 62.37) |
| >500,000 cigarettes/life | 9 | 5 | 11.51 | (3.19– 41.57) | 1 | 5 | 1.70 | (0.15– 19.05) | 8 | 5 | 116.10 | (18.74– 718.90) |
| Ptrend | 0.084 | 0.412 | 0.138 | |||||||||
| Tobacco smoking packyears | ||||||||||||
| Never | 45 | 166 | 1.00 | 33 | 166 | 1.00 | 5 | 166 | 1.00 | |||
| >0–20 py | 24 | 46 | 2.15 | (1.11– 4.17) | 12 | 46 | 1.27 | (0.55– 2.94) | 10 | 46 | 13.02 | (3.40– 49.80) |
| 21–40 py | 18 | 37 | 2.55 | (1.20– 5.40) | 5 | 37 | 0.85 | (0.26– 2.83) | 8 | 37 | 12.84 | (3.10– 53.18) |
| >40 py | 30 | 22 | 7.75 | (3.55– 16.93) | 8 | 22 | 2.75 | (0.94– 8.03) | 21 | 22 | 53.11 | (13.13– 214.90) |
| Ptrend | 0.004 | 0.282 | 0.010 | |||||||||
Adjusted for center, education, sex, and age
Results on esophagus and cigar or pipe were not included due to sparse data.
Among never tobacco smokers, ever exposure to involuntary smoking at home or at work was associated with an increased risk of UADT SCC (Table 5). The estimates for the associations with involuntary smoking exposure either at home only or at work only were similar with overlapping 95% confidence intervals. Duration of exposure at home and at work combined was observed to be associated with UADT SCC risk overall (OR=1.84, 95%CI 1.17–2.89 for >15 years of exposure; p trend = 0.007), and more specifically with oral cavity/oropharyngeal cancers (OR=2.15, 95%CI 1.21–3.80 for >15 years of exposure; p trend = 0.007). When stratifying the cancer subsites into finer groups, the ORs for ever involuntary smoking status were 2.45 (95%CI 1.20–5.01) for oral cavity cancer, 1.35 (95%CI 0.58–3.15) for pharyngeal cancer, and 1.76 (95%CI 0.64–4.87) for laryngeal cancer (data not shown). Dose-response relations with exposure at home and at work were observed for oral cavity cancer (p for trend=0.002) (data not shown), but not for the other cancer subsites. When we removed the adjustment for alcohol drinking, the ORs fluctuated only slightly and 95% CIs remained overlapping (OR=1.82, 95%CI 1.17–2.84 for >15 years of exposure in cancers of the UADT; OR=2.10, 95%CI 1.19–3.68 for >15 years of exposure in cancers of the oral cavity and oropharynx) (data not shown).
Table 5.
Association between involuntary smoking and UADT cancer, overall and by cancer subsite
| UADT | Oral cavity & oropharynx | Larynx & hypopharynx | Esophagus | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ca | Co | OR | 95%CI | Ca | Co | OR | 95%CI | Ca | Co | OR | 95%CI | Ca | Co | OR | 95%CI | |
| Passive smoking exposure | ||||||||||||||||
| Never | 39 | 212 | 1.00 | 21 | 212 | 1.00 | 7 | 212 | 1.00 | 9 | 198 | 1.00 | ||||
| Ever at home only | 54 | 182 | 1.49 | (0.90– 2.48) | 36 | 182 | 1.72 | (0.91– 3.22) | 9 | 182 | 2.01 | (0.66– 6.14) | 6 | 164 | 0.68 | (0.19– 2.46) |
| Ever at work only | 35 | 122 | 1.79 | (1.03– 3.13) | 25 | 122 | 2.46 | (1.24– 4.87) | 7 | 122 | 1.72 | (0.55– 5.44) | 3 | 111 | 0.96 | (0.21– 4.33) |
| Ever both at home and at work | 52 | 190 | 1.68 | (1.00– 2.83) | 29 | 190 | 1.62 | (0.84–3.14) | 11 | 190 | 2.34 | (0.74– 7.40) | 6 | 151 | 0.74 | (0.21– 2.68) |
| Ever at home or work | 141 | 494 | 1.63 | (1.06– 2.51) | 90 | 494 | 1.87 | (1.08– 3.23) | 27 | 494 | 1.98 | (0.77– 5.07) | 15 | 426 | 0.76 | (0.27– 2.12) |
| Duration of exposure at home | ||||||||||||||||
| Never | 75 | 338 | 1.00 | 46 | 338 | 1.00 | 14 | 338 | 1.00 | 13 | 313 | 1.00 | ||||
| 1–15 years | 26 | 104 | 0.98 | (0.56–1.69) | 14 | 104 | 0.80 | (0.40– 1.62) | 7 | 104 | 2.00 | 2.00 (0.67– 5.96) | 1 | 95 | 0.15 | (0.01–1.68) |
| >15 years | 66 | 191 | 1.50 | (0.97– 2.32) | 44 | 191 | 1.50 | (0.89–2.53) | 9 | 191 | 1.68 | 1.68 (0.62– 4.52) | 10 | 168 | 1.28 | (0.43–3.78) |
| Ptrend | 0.073 | 0.133 | 0.269 | 0.661 | ||||||||||||
| Duration of exposure at work | ||||||||||||||||
| Never | 92 | 392 | 1.00 | 56 | 392 | 1.00 | 16 | 392 | 1.00 | 15 | 360 | 1.00 | ||||
| 1–15 years | 34 | 137 | 1.14 | (0.70– 1.86) | 20 | 137 | 1.04 | (0.56– 1.93) | 8 | 137 | 1.86 | (0.70– 4.93) | 4 | 116 | 1.00 | (0.27– 3.67) |
| >15 years | 52 | 174 | 1.65 | (1.06– 2.57) | 33 | 174 | 1.92 | (1.12– 3.28) | 10 | 174 | 1.18 | (0.47–2.97) | 5 | 145 | 0.97 | (0.28– 3.40) |
| Ptrend | 0.029 | 0.025 | 0.624 | 0.964 | ||||||||||||
| Duration of exposure both at home and at work | ||||||||||||||||
| Never | 39 | 212 | 1.00 | 21 | 212 | 1.00 | 7 | 212 | 1.00 | 9 | 198 | 1.00 | ||||
| 1–15 years | 35 | 144 | 1.31 | (0.75– 2.28) | 22 | 144 | 1.38 | (0.68– 2.78) | 9 | 144 | 2.38 | (0.78– 7.30) | 1 | 127 | 0.15 | (0.02– 1.44) |
| >15 years | 101 | 320 | 1.84 | (1.17– 2.89) | 64 | 320 | 2.15 | (1.21– 3.80) | 17 | 320 | 1.82 | (0.67– 4.92) | 14 | 277 | 1.11 | (0.39– 3.14) |
| Ptrend | 0.007 | 0.007 | 0.313 | 0.635 | ||||||||||||
Adjusted by age, sex, education, center, alcohol drinking intensity and duration (categorical)
Discussion
The association with active tobacco smoking was stronger for cancer risk of hypopharynx and larynx than for that of oral cavity and oropharynx and esophagus, consistent with previous findings (3) (4). Tobacco smoking was suggested to have an independent effect from alcohol drinking for laryngeal and hypopharyngeal cancers but not for oral cavity and oropharyngeal cancers. Heterogeneity across cancer subsites was detected for all tobacco smoking variables except for age at start smoking. Differences in UADT SCC risk associated with cigarettes, cigars and pipes were suggested by the point estimates. Boffetta et al. suggested that different inhalation pattern may have an impact on the results (13). The observations that “cigar only smokers” seldom inhale into the lung, while former cigarette smokers and concurrent cigar and cigarette smokers tend to keep their cigarette inhalation pattern when they smoke cigars (14) supports our results that cigar smoking might have a stronger association with oral cavity and oropharynx. However, we were not able to adjust for inhalation patterns.
The observation that an association with cigar smoking was stronger than that with cigarette or pipe smoking might be due to chance with the sparse data or due to the higher delivered dosages of nicotine, tar and CO in cigars than in cigarettes according to machine-smoking analysis (15). The levels of nicotine, benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were found to be higher in the mainstream smoke of premium cigars, even the cigarette-size cigars (15).
Among never alcohol drinkers, an association with tobacco smoking for oral cavity and oropharyngeal cancer was not observed. One possible reason is that there might not be adequate power to detect a moderate effect of smoking on oral cavity and oropharyngeal cancer development. Another possible reason is that a potential smoking effect on the oral cavity may require exposure to alcohol consumption (16), whereas the effect of smoking on larynx and hypopharynx is independent of alcohol consumption. The findings that the association with active smoking was stronger for laryngeal and pharyngeal cancers than that for oral cavity cancer are consistent with those in the pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium (4). The interactions detected between tobacco smoking and alcohol drinking further supports the necessary role of alcohol drinking in the mechanism for the relationship between tobacco smoking and the development of oral cavity and oropharyngeal cancers.
Among never tobacco smokers, the association with involuntary smoking that we observed for oral cavity and oropharyngeal cancers has not been reported in previous studies (10). This association might be real or might be due to residual confounding of alcohol drinking. Unfortunately, we did not have enough power to investigate the relationship among never alcohol drinkers. The difference between the ORs with and without the adjustment for alcohol drinking was minimal. Thus, the residual confounding by alcohol might be minimal. Associations between involuntary smoking and pharyngeal and laryngeal cancers have been reported in the pooled analysis in the INHANCE consortium (10). However, the associations between involuntary smoking and pharyngeal and laryngeal cancers were suggestive in our analysis since the CIs included the null value and no dose-response relationship was observed with duration of exposure.
There are some limitations in our present analysis. There might be selection bias due to the use of hospital controls for most of the study centers. However, oversampling of long stay patients or patients within a specific diagnostic group was avoided. Most controls were patients who had been in the hospital for shorter than one week. We expect selection bias in our study to be minimal. In order to assess the impact of any potential selection bias due to the control selection, we compared the results stratified by control type (hospital-based and population-based). The point estimates for the population-based controls were higher than those from the hospital-based controls with overlapping 95% CI, which suggested our results might be biased towards the null since most of the controls were hospital-based and might result in nondifferential reporting bias. In addition, recall bias might be a concern since the interviews were performed after disease diagnosis.
Though our study was large-scale, some analyses were difficult to carry out due to sparse data. For instance, we were not able to examine subjects who only smoked a certain type of tobacco product, since the prevalence of cigar only smokers (n=4) or pipe only smokers (n=9) was low among cancer cases in our study population. Furthermore, the number of esophageal SCC cases was fairly small; thus, we focused on the main effects for tobacco and cigarette smoking for the analysis of esophageal SCC cases.
Although we had the statistical power to examine the association of involuntary smoking with the risk of UADT cancers among never tobacco smokers, there was not enough power to assess that among never tobacco and never alcohol users. The association with involuntary smoking exposure both at home and at work was observed to be similar to that with exposure either at home only or at work only probably due to the limitation of no adjustment by exposure intensity.
In addition, confounding by family history of cancer and by human papillomavirus (HPV) infection might be of concern in our investigation. According to a recent pooled analysis in INHANCE consortium, family history of head and neck cancer was found to be associated with an increased risk of head and neck cancer (OR=2.2, 95% CI 1.6–3.1 when the affected relative was a sibling) (17). However, we do not have the information on family history of cancer available for further investigation in our study. Negri et al. reported that subjects with family history of head and neck cancer was not associated with an increased risk of head and neck cancer when exposure to tobacco was absent (17). Furthermore, when we considered the magnitude of the point estimates for the association with family history of cancer, the association with tobacco smoking could not have been fully explained by family history of cancer.
High-risk types of HPV have been associated with a higher risk of a subgroup of head and neck squamous cell carcinoma (18). Confounding by HPV status might affect the association between tobacco smoking and UADT cancers. Although we did not have any HPV information available in this study population, we suspected the impact of HPV confounding, if any, to result in bias towards the null value because HPV-positive patients tended to be younger and nonsmokers and nondrinkers (18), (19). Tobacco smoking/alcohol drinking and HPV infection were hypothesized to be two distinct pathogenic mechanisms (19), (18). Despite the above-mentioned potential limitations, this study provides a more homogeneous population within Europe and more adequate power for evaluating the main effect of tobacco smoking among never alcohol drinkers and by cancer subsite.
According to the assessment of false positive report probability, the detected associations with active tobacco smoking were robust, while the observed associations with involuntary smoking warrant further investigation with a larger sample size. In summary, an independent effect of tobacco smoking from alcohol drinking for hypopharyngeal/laryngeal cancer was more substantial than that for oral cavity/oropharyngeal cancers. Our results corroborate that active tobacco smoking may play a stronger role in the development of hypopharyngeal and laryngeal cancers than that of oral cavity and oropharyngeal cancers among never alcohol drinkers. In addition, avoiding exposure to involuntary smoking is important for the prevention of UADT cancers. For future direction, it is important to investigate the effect of tobacco smoking by type of tobacco in a larger study population of cigar only and/or pipe only smokers.
Acknowledgements
The authors thank all the study participants for their contribution. The authors are also grateful to the support from many clinicians and staff of the hospitals, interviewers, data managers, pathology department, and primary care clinics. In the Glasgow center, we would also indebted to Dr Gerry Robertson from the Beatson Oncology Center and Mr John Devine from the Southern General Hospital. GJM and TVM partly worked on this study while at the University of Manchester. We acknowledge the help of Dr Richard Oliver, Professor Martin Tickle and Dr Ann-Marie Biggs in study conduct in the Manchester center and Professor Phil Sloan and Professor Nalin Thakker who in addition coordinated sample collection and processing for all the UK centers.
Financial Support
Funding was received from European Community (5th Framework Programme) grant no. QLK1-CT-2001-00182, University of Athens Medical School (for the Athens center), and Compagnia di San Paolo and Italian Association for Cancer Research (for the Turin center). YCAL worked on this project during the Special Training Award Fellowship for post-doctoral fellows at the International Agency for Research on Cancer (IARC) and the post-doctoral fellowship in the Cancer Epidemiology Training Program (T32 CA09142) at University of California at Los Angeles. MM was sponsored by a Special Training Award at IARC. None of the sponsors had any role in the design and conduct of the report; collection, management, analysis, and interpretation of the data; or preparation, review and approval of this manuscript.
References
- 1.IARC Working Group. Tobacco smoke and involuntary smoking. 2004. pp. 1–1438. [PMC free article] [PubMed] [Google Scholar]
- 2.Fan Y, Yuan JM, Wang R, Gao YT, Yu MC. Alcohol, tobacco, and diet in relation to esophageal cancer: the shanghai cohort study. Nutr Cancer. 2008;60:354–363. doi: 10.1080/01635580701883011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99–106. doi: 10.1093/jnci/djh014. [DOI] [PubMed] [Google Scholar]
- 4.Hashibe M, Brennan P, Benhamou S, et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst. 2007;99:777–789. doi: 10.1093/jnci/djk179. [DOI] [PubMed] [Google Scholar]
- 5.Kauppinen T, Toikkanen J, Pedersen D, et al. Occupational exposure to carcinogens in the European Union. Occup Environ Med. 2000;57:10–18. doi: 10.1136/oem.57.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Ong MK, Glantz SA. Cardiovascular health and economic effects of smoke-free workplaces. Am J Med. 2004;117:32–38. doi: 10.1016/j.amjmed.2004.02.029. [DOI] [PubMed] [Google Scholar]
- 7.Jaakkola MS, Jaakkola JJ. Impact of smoke-free workplace legislation on exposures and health: possibilities for prevention. Eur Respir J. 2006;28:397–408. doi: 10.1183/09031936.06.00001306. [DOI] [PubMed] [Google Scholar]
- 8.Tan EH, Adelstein DJ, Droughton ML, Van Kirk MA, Lavertu P. Squamous cell head and neck cancer in nonsmokers. Am J Clin Oncol. 1997;20:146–150. doi: 10.1097/00000421-199704000-00008. [DOI] [PubMed] [Google Scholar]
- 9.Zhang ZF, Morgenstern H, Spitz MR, et al. Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2000;9:1043–1049. [PubMed] [Google Scholar]
- 10.Lee YC, Boffetta P, Sturgis EM, et al. Involuntary smoking and head and neck cancer risk: pooled analysis in the international head and neck cancer epidemiology consortium. Cancer Epidemiol Biomarkers Prev. 2008;17:1974–1981. doi: 10.1158/1055-9965.EPI-08-0047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Lagiou P, Georgila C, Minaki P, et al. Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur J Cancer Prev. 2008 doi: 10.1097/CEJ.0b013e32830c8dca. [DOI] [PubMed] [Google Scholar]
- 12.Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434–442. doi: 10.1093/jnci/djh075. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Boffetta P, Pershagen G, Jockel KH, et al. Cigar and pipe smoking and lung cancer risk: a multicenter study from Europe. J Natl Cancer Inst. 1999;91:697–701. doi: 10.1093/jnci/91.8.697. [DOI] [PubMed] [Google Scholar]
- 14.Fant RB, Henningfield JE. Pharmacology and abuse potential of cigars. Bethesda MD: National Cancer Institute; 1998. Cigars: Health Effects and Trends (Smoking and Tobacco Control Monograph. [Google Scholar]
- 15.Rickert WS, Kaiserman MJ. Application of proposed Canadian test methods to the analysis of cigarette filler, fine cut tobacco, and tobacco smoke (Abstract No 16) Montreal, Canada: 1999. [Google Scholar]
- 16.Castellsague X, Quintana MJ, Martinez MC, et al. The role of type of tobacco and type of alcoholic beverage in oral carcinogenesis. Int J Cancer. 2004;108:741–749. doi: 10.1002/ijc.11627. [DOI] [PubMed] [Google Scholar]
- 17.Negri E, Boffetta P, Berthiller J, et al. Family history of cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Int J Cancer. 2009;124:394–401. doi: 10.1002/ijc.23848. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;%19;100:407–420. doi: 10.1093/jnci/djn025. [DOI] [PubMed] [Google Scholar]
- 19.Baumann JL, Cohen S, Evjen AN, et al. Human papillomavirus in early laryngeal carcinoma. Laryngoscope. 2009;119:1531–1537. doi: 10.1002/lary.20509. [DOI] [PubMed] [Google Scholar]